Clinical Trials

Carcinoma, Hepatocellular

NCT07564466 2026-05-11

A Study of SKB571 in Participants With Gastrointestinal Tumors

120 enrolled

EndocrineGastrointestinalNET

Digestive System Neoplasms

NCT07165886 2026-04-24

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Phase 2/3 Recruiting

298 enrolled

Gastroenteropancreatic Neuroendocrine Tumors

NCT06431490 2026-04-08

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Phase 1/2 Recruiting

102 enrolled

Biliary Tract Neoplasms

NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Phase 1/2 Suspended

15 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT07450976 2026-03-31

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

151 enrolled

Biliary Tract Neoplasms

NCT06821503 2026-03-10

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Phase 1/2 Recruiting

72 enrolled

Advanced Pancreatic Cancer

NCT06752811 2026-02-10

pompom

416 enrolled

Pancreatic Cancer Metastatic

NCT07398339 2026-02-09

DVDMS

Biliary Tract Neoplasms

NCT07229625 2026-01-28

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

604 enrolled

Advanced Biliary Tract Cancer

NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

EndocrineGastrointestinalGenitourinaryNET

27 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

NCT07348211 2026-01-23

SIM0610-101

GastrointestinalHead & NeckThoracic

260 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT07110571 2026-01-09

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

200 enrolled

Stomach Neoplasms

NCT04643405 2026-01-08

APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

Phase 1/2 Terminated

21 enrolled

Phase 2/3 Not yet recruiting

Pancreatic Neoplasms

NCT07321847 2026-01-07

INJECTABL-3

717 enrolled

DermatologicGastrointestinalOther solid neoplasmThoracic

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05047536 2025-12-19

KZR-261 in Subjects With Advanced Solid Malignancies

Phase 1 Terminated

61 enrolled 25 charts

Uveal Melanoma, Melanoma, Mesothelioma, Neoplasm Metastasis, Colorectal Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Phase 3 Not yet recruiting

320 enrolled

Pancreatic Neoplasms

NCT04727307 2025-09-30

AB-LATE02

202 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT06526338 2025-09-30

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

126 enrolled

Carcinoma, Hepatocellular

NCT06947291 2025-09-08

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

GastrointestinalOther solid neoplasm

350 enrolled

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT07151872 2025-09-03

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

120 enrolled

CLDN18.2-positive Advanced Biliary Tract Cancer

NCT05229588 2025-08-15

Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations

Phase 2 Completed

8 enrolled

Gastrointestinal Malignancies

NCT06356688 2025-08-08

A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT04778839 2025-08-06

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

BreastGastrointestinalGynecologicThoracic

98 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms

NCT06205849 2025-07-25

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

18 enrolled

Phase 2 Active not recruiting

Pancreatic Neoplasms

NCT03350126 2025-07-23

NIPICOL

57 enrolled

Colonic Neoplasms, Microsatellite Instability

NCT06199895 2025-06-03

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

BreastGastrointestinalThoracic

25 enrolled

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05870800 2025-05-25

NICER

28 enrolled

Phase 1 Not yet recruiting

Colonic Neoplasms

NCT06948539 2025-04-29

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

66 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

NCT05342194 2025-04-23

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

480 enrolled

Phase 1 Not yet recruiting

Cholangiocarcinoma

NCT06913218 2025-04-06

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

60 enrolled

Phase EARLY_PHASE1 Recruiting

Pancreatic Neoplasms

NCT04048278 2025-03-03

Lidocaine Infusion in Pancreatic Cancer

46 enrolled

Pancreatic Neoplasms

NCT04863430 2025-02-21

Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach

Phase 2 Withdrawn

Phase 1/2 Active not recruiting

Stomach Neoplasms

NCT05688280 2025-01-08

INJECTABL-1

42 enrolled

DermatologicGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Sarcoma

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

40 enrolled

Locally Advanced Rectal Cancer

NCT03511963 2024-12-31

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Phase 3 Completed

677 enrolled

Colorectal Neoplasms

NCT06558227 2024-12-16

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

90 enrolled

Phase 1 Not yet recruiting

Carcinoma, Hepatocellular

NCT06710561 2024-12-03

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.

32 enrolled

Colorectal Neoplasms

NCT06296706 2024-11-14

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

630 enrolled

Phase 1/2 Not yet recruiting

Stomach Neoplasms

NCT06662669 2024-10-29

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

120 enrolled

Phase 1/2 Not yet recruiting

Pancreatic Neoplasms

NCT06641453 2024-10-16

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT06599775 2024-09-19

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

42 enrolled

BreastGastrointestinalThoracic

Resectable Esophageal Squamous Cell Carcinoma

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

260 enrolled

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06486545 2024-08-26

Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

Phase NA Not yet recruiting

18 enrolled

Stomach Neoplasms

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

65 enrolled

Phase 3 Not yet recruiting

Esophageal Squamous Cell Carcinoma

NCT06492941 2024-07-09

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

142 enrolled

Advanced Pancreatic Cancer

NCT06415669 2024-05-29

A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

Stomach Neoplasms

NCT04676633 2024-03-19

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Phase 1 Completed

5 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04714190 2023-12-21

A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

Phase 3 Unknown

351 enrolled

Stomach Neoplasms

NCT04329429 2023-12-20

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

Phase 2 Unknown

57 enrolled